METHODS	From 1997 to 2003 , patients aged 35 to 75 years , operated more than 2 years previously for monolateral breast cancer without adjuvant TAM , with no signs of metastases and no contraindication to TAM were randomized to TAM 20 mg/day orally for 2 years or follow-up alone .\